Navigation Links
Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
Date:9/30/2010

eivable (11,000) (11,000) Retained earnings 92,797,859 67,888,667 Statutory reserves 3,253,878 3,253,878 Accumulated other comprehensive income 7,617,703 6,523,602 Total shareholders' equity 134,517,057 126,063,376 Total liabilities and shareholders' equity $202,340,274 $168,742,463 JIANGBO PHARMACEUTICALS, INC. AND SUBSIDIARIES (FORMERLY GENESIS PHARMACEUTICALS ENTERPRISES, INC.) CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (Unaudited) For the For the Three Months Ended Twelve Months Ended June 30, June 30, 2010 2009 2010 2009 REVENUES: Sales $29,308,512 $31,152,620 $97,443,897 $117,143,950 Sales- related parties -- 83 -- 244,026 TOTAL REVENUES, net 29,308,512 31,152,703 97,443,897 117,387,976 Cost of sales 8,195,200 8,149,727 26,097,103 27,854,747 Cost of sales - related parties -- 19 -- 54,519 COST OF SALES 8,195,200 8,149,746 26,097,103 27,909,266 GROSS PROFIT 21,113,312 23,002,957 71,346,794 89,478,710 RESEARCH AND DEVELOPMENT EXPENSE 1,100,700 1,099,875 4,400,100 4,395,000 SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 5,331,689 4,203,777 18,731,844 35,315,529 INCOME FROM OPERATIONS 14,680,923 17,699,305 48,214,850 49,768,181 OTHER (INCOME) EXPENSE, NET: Change in fair value of derivative liabilities (1,141,384) -- (14,631,455) -- Non-operating expense (income), net 162,061 (257,927) 382,122 804,561 Non-operating expense (income) - related party (80,718) (69,694) (322,674) (382,970) Interest expense, net 4,233,550 1,760,543 19,796,531 5,904,511 Loss from discontinued operations 43,023 88,116 243,792 1,781,946 OTHER EXPENSE, NET 3,216,532 1,521,038 5,468,316 8,108,048 INCOME BEFORE PROVISION FOR INCOME TAXES 11,464,391 16,178,267 42,746,534 41,660,133 PROVISION FOR INCOME TAXES 4,278,118 4,686,549 12,896,179 12,779,869 NET INCOME $7,186,273 $11,491,718 $29,850,355 $28,880,264 OTHER COMPREHENSIVE INCOME: Unrealized gain (loss) on marketable securities 77,843 633,412 166,378 (1,514,230) Foreign currency translation adjustment 730,330 (41,357) 92
'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
2. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
3. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
4. Jiangbo Pharmaceuticals Announces the Appointment of New Chief Executive Officer
5. Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
6. Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
7. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
8. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
9. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
10. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
11. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... LONGMONT, Colo. , Aug. 27, 2015 /PRNewswire/ ... focused on the development of Next Generation ... for applications in high speed fiber-optic data ... Michael Lebby has been appointed to ... Lebby,s reputation in the field of optoelectronics is ...
(Date:8/27/2015)... and SOUTH SAN FRANCISCO, Calif. ... Fibrosis Foundation (PFF) and Veracyte, Inc. ... organizations are partnering on a U.S. patient survey ... interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis ... survey will assess the steps and time required ...
(Date:8/27/2015)... , Aug. 27, 2015  QB3@953—a ... a University of California (UC) research institute and ... company GSK to identify and facilitate collaborations to ... benefit patients. The agreement formalizes a ... Academia (DPAc) team and creates a new channel ...
Breaking Medicine Technology:Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 2Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 4QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities 2
... 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), ... on cardiac and vascular surgery, announced today that it ... of Vice President, Research and Development; and David P. ... Market Development Surgical Adhesives and Starch Medical Relations.  Dr. ...
... LOUIS, Jan. 4, 2012 Express Scripts now provides ... HealthBridge Pharma & Biotech services. CuraScript, a wholly owned ... suite of services, will be among a limited number ... EYLEA (aflibercept) Injection was approved by the ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA™ (aflibercept) Injection 2
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... solutions and creators of CMaps Analytics, announced a new location analytics designer for ... professionals to create a wide range of maps experiences in the cloud and ...
(Date:8/27/2015)... ... August 27, 2015 , ... An inventor from Gibertsville, Pa., knows how knees ... against each other while I’m trying to sleep," he said, "so I decided that ... easy-to-use, ergonomic BTKG BED TIME KNEE GUARD helps a user get a better sleep ...
(Date:8/27/2015)... ... 27, 2015 , ... Doctors in the US, the UK and Switzerland say ... especially if given when cells are in the stage known as autophagy. Surviving Mesothelioma ... full article. , Cancer investigators with the University of California, the University of ...
(Date:8/27/2015)... ... August 27, 2015 , ... Generate fully customizable three dimensional ... within Final Cut Pro X. , With ProGeo Refraction, a FCPX Plugin ... do. Users can generate fully customizable three dimensional geometric shape refraction all within Final ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... After conducting ... Smith, Ephraim McDowell Health in Danville, Ky., has hired Burt Piper, as ... leadership experience, Piper will assume his new duties on September 28. , “Burt is ...
Breaking Medicine News(10 mins):Health News:CMaps Analytics Announces New Location Intelligence Integration for SAP Lumira 2Health News:New Research Unveils Potential Method for Improved Response to Mesothelioma Drug, According to Surviving Mesothelioma 2Health News:Announcing a New FCPX Plugin, ProGeo Refraction from Pixel Film Studios. 2Health News:Ephraim McDowell Health Hires New Chief Operating Officer 2Health News:Ephraim McDowell Health Hires New Chief Operating Officer 3
... of actual resveratrol plus 95% OPCs ... and three ... manufacturer,Renaissance Health Publishing, LLC, is disappointed and confused as to ... of Revatrol, and calls on the for-profit laboratory,to remove the ...
... often be the smarter choice, study suggests , MONDAY, Nov. ... symptoms of throat infection, surgery to remove the tonsils is ... watching and waiting to see if symptoms resolve, a Dutch ... University Medical Center Utrecht compared 151 children, ages 2 to ...
... McCandliss, a psychologist at the Sackler Institute for Developmental ... Weill Cornell Medical College, has received a commendation by ... of a Presidential Early Career Award for Scientists and ... by the U.S. government for outstanding scientists and engineers ...
... new article appearing in American Journal of Transplantation describes ... of organ rejection in kidney transplants. The technique, which ... examining DNA sequences, defines how major causes of organ ... behavior. The study is the first to show how ...
... Booker, II, CPA, Presented with Charles Kopke,Medal ... Nov. 19 The American,Diabetes Association (ADA), ... fight against diabetes, announced today that G. ... Arkansas, received the,Association,s prestigious Charles Kopke Medal ...
... an,important step toward protecting patient access to essential ... Fracture Prevention and,Osteoporosis Testing Act of 2007," sponsored ... a reversal of drastic Medicare cuts,to DXA (dual ... the gold standard for measuring bone mass to ...
Cached Medicine News:Health News:ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing 2Health News:ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing 3Health News:Tonsillectomy Not Always Cost-Effective for Kids' Throat Woes 2Health News:White House awards Weill Cornell's Bruce McCandliss highest honor for early career scientists 2Health News:Breakthrough in organ rejection diagnosis examines gene behavior 2Health News:Bill Booker Receives American Diabetes Association's Distinguished Service Award 2Health News:Bill Booker Receives American Diabetes Association's Distinguished Service Award 3Health News:Congress Moves to Protect Bone Health 2